These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 6363349)

  • 1. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubella immunity measured by hemagglutination inhibition and enzyme-linked immunosorbent assay.
    Hornstein L; Swartz TA; Heimann M
    Isr J Med Sci; 1985 Aug; 21(8):666-9. PubMed ID: 4044233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different methods for assessment of rubella infection and immunity.
    Braun R; Hornig C; Sann G; Doerr HW
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep; 252(4):431-7. PubMed ID: 6758420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of congenital rubella and the immunity status to rubella in the Jerusalem area.
    Isacsohn M; Rudensky B; Eidelman AI; Paz E; Weintraub G; Nubani N; Swartz TA
    Isr J Med Sci; 1983 Oct; 19(10):929-33. PubMed ID: 6363348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selective and controlled mass rubella vaccination - experiences with an economical method (author's transl)].
    Zippel C; Federmann G; Leidel J; Eggers HJ
    Immun Infekt; 1982 Mar; 10(2):69-75. PubMed ID: 7040210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigations on the dependency of hemagglutination inhibition titers against rubella virus on the number and quality of antibody molecules (author's transl)].
    Hoppe G
    Zentralbl Bakteriol A; 1981; 249(2):143-51. PubMed ID: 7269848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rubella antibodies in women of childbearing age during an epidemic and the two years thereafter.
    Hornstein L; Ben-Porath E
    Isr J Med Sci; 1976 Oct; 12(10):1189-93. PubMed ID: 990135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
    Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
    J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibody response to live rubella vaccination and its clinical meanings].
    Hoshiba T; Yabuki Y; Asamoto A; Kimura N; Tanaka J
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2029-35. PubMed ID: 3429985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme linked immunosorbent assay of rubella antibody.
    Kikuchi T; Kuno-Sakai H; Kimura M
    Tokai J Exp Clin Med; 1983 Jul; 8(3):275-9. PubMed ID: 6367150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the effects of active rubella vaccination. Comparative studies of the evaluation of seroconversion using the ELISA technic and the hemagglutination inhibition test].
    Dennin RH; Husstedt W
    Fortschr Med; 1983 Mar; 101(11):482-5. PubMed ID: 6343205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the management of pregnant women having high hemagglutination inhibition (HI) antibody titer of rubella virus in the first trimester examination of rubella virus antibody in the pregnant women having high HI titer by different methods and prognosis of their infants after birth].
    Hoshiba T; Yabuki Y; Asamoto A; Kimura N; Tanaka J
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):1993-9. PubMed ID: 3429981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
    Rossier E; Phipps PH; Polley JR; Webb T
    Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reasons for repeated serologically unsuccessful (HAI-HIG test) rubella vaccination (author's transl)].
    Ehrengut W; Florent G
    Dtsch Med Wochenschr; 1981 Jul; 106(31-32):987-9. PubMed ID: 7261921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center.
    Okuda M; Yamanaka M; Takahashi T; Ishikawa H; Endoh M; Hirahara F
    J Obstet Gynaecol Res; 2008 Apr; 34(2):168-73. PubMed ID: 18412777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between a commercial ELISA, Rubazyme, and hemolysis-in-gel test for determination of rubella antibodies.
    Grillner L; Forsgren M; Nordenfelt E
    J Virol Methods; 1985 Feb; 10(2):111-5. PubMed ID: 3884643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postinfection and postvaccination antirubella immunity.
    Kańtoch M; Imbs D
    Acta Virol; 1986 Sep; 30(5):381-9. PubMed ID: 2878585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001.
    Malakmadze N; Zimmerman LA; Uzicanin A; Shteinke L; Caceres VM; Kasymbekova K; Sozina I; Glasser JW; Joldubaeva M; Aidyralieva C; Icenogle JP; Strebel PM; Reef SE
    Clin Infect Dis; 2004 Jun; 38(12):1780-3. PubMed ID: 15227627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of antibodies to rubella virus with the disperse dye immunoassay (DIA) in comparison with an enzyme-linked immunosorbent assay (ELISA).
    Rothe U; Lasch J; Römer I; Sandow D; Hübner G; Rosmus K; Kiessig ST; Porstmann T
    Biomed Biochim Acta; 1986; 45(10):1325-32. PubMed ID: 3566722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.